Wellbeing Digital Sciences Inc. (KONEF) Research

With its origins as KetamineOne Capital Limited, this innovative wellness organization is dedicated to advancing ketamine-assisted therapy and psychedelic medicines. It achieves this mission by managing a network of healthcare clinics across North America. The company, which commenced operations in 2017 and is headquartered in Vancouver, Canada, was formerly recognized as Myconic Capital Corp. Its transition to the KetamineOne Capital Limited name occurred in June 2021.

Market snapshot

Symbol
KONEF
Price
$0.00
Day change
0.00%
Market cap
$4.5M
P/E ratio
-0.18x
52-week range
0.000001-0.00001
Sector
Healthcare
Industry
Medical - Care Facilities

Peer companies

  • Coloplast A/S (CLPBF)
  • Coloplast A/S (CLPBY)
  • Lynx Global Digital Finance Corporation (CNONF)
  • Fresenius Medical Care AG & Co. KGaA (FMCQF)
  • JD Health International Inc. (JDHIF)
  • Otsuka Holdings Co., Ltd. (OTSKF)
  • Sartorius Stedim Biotech S.A. (SDMHF)
  • Teva Pharmaceutical Industries Limited (TEVJF)

Open Wellbeing Digital Sciences Inc. (KONEF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.